Top Markets
Coin of the day
Metsera, Inc. Metsera, Inc.

Metsera, Inc.

MTSR
Rang in aandelen #2738
Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in... Metsera, Inc. operates as a clinical-stage biotechnology firm, specializing in crafting both injectable and oral nutrient-stimulated hormone analog peptides. These therapeutic compounds are primarily aimed at addressing obesity, overweight conditions, and associated health issues. Its developmental pipeline features MET-097i and MET-233i, both under investigation for treating obesity and overweight patients. Furthermore, Metsera is advancing a potential combination therapy involving MET-233i and MET-097i. The company is also progressing additional drug candidates, including MET-002, MET-224o, MET-067i, and MET-034i, all of which target disorders such as diabetes and obesity. Founded in 2022, Metsera, Inc. maintains its corporate headquarters in New York, New York.
Aandeelprijs
$70.50
Laatst gesynchroniseerd: 2025-11-14
Marktkapitalisatie
$7.33B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
116.32%
Land
US
Handel Metsera, Inc. (MTSR)

Categorie

Koersgeschiedenis voor Metsera, Inc. (MTSR)
Hoogste slotkoers: $72.34 op 2025-11-01

Laagste slotkoers: $26.50 op 2025-01-01
Koersgeschiedenis van Metsera, Inc. van 2025 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -29.98%
2025 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$553.09 42.20%
US
$1.02K 50.56%
NL
$158.64 525.80%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH